Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP362631.RAFd0S9aul6-sp2l0zgv0X579FfHgjdb9UPTrI7IhGZZk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP362631.RAFd0S9aul6-sp2l0zgv0X579FfHgjdb9UPTrI7IhGZZk130_assertion type Assertion NP362631.RAFd0S9aul6-sp2l0zgv0X579FfHgjdb9UPTrI7IhGZZk130_head.
- NP362631.RAFd0S9aul6-sp2l0zgv0X579FfHgjdb9UPTrI7IhGZZk130_assertion description "[The tumor necrosis factor-alpha (TNFalpha) -238 polymorphism was significantly underrepresented in cervical cancer patients [heterozygotes (HETs), odds ratio (OR) = 0.33; 95% confidence interval (CI), 0.11-0.96], as was the TNFalpha -376 polymorphism (P = 0.02; 0% for any variant genotype in cases vs 4.7% in controls).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP362631.RAFd0S9aul6-sp2l0zgv0X579FfHgjdb9UPTrI7IhGZZk130_provenance.
- NP362631.RAFd0S9aul6-sp2l0zgv0X579FfHgjdb9UPTrI7IhGZZk130_assertion evidence source_evidence_literature NP362631.RAFd0S9aul6-sp2l0zgv0X579FfHgjdb9UPTrI7IhGZZk130_provenance.
- NP362631.RAFd0S9aul6-sp2l0zgv0X579FfHgjdb9UPTrI7IhGZZk130_assertion SIO_000772 12142377 NP362631.RAFd0S9aul6-sp2l0zgv0X579FfHgjdb9UPTrI7IhGZZk130_provenance.
- NP362631.RAFd0S9aul6-sp2l0zgv0X579FfHgjdb9UPTrI7IhGZZk130_assertion wasDerivedFrom befree-2016 NP362631.RAFd0S9aul6-sp2l0zgv0X579FfHgjdb9UPTrI7IhGZZk130_provenance.
- NP362631.RAFd0S9aul6-sp2l0zgv0X579FfHgjdb9UPTrI7IhGZZk130_assertion wasGeneratedBy ECO_0000203 NP362631.RAFd0S9aul6-sp2l0zgv0X579FfHgjdb9UPTrI7IhGZZk130_provenance.